7-dehydrocholesterol
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Feb 20, 2025 (NCT07012161)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 1 Sponsor(trial)
Mechanism of action
- CholesterolSupplementation
cholesterol supplementation
Chemistry & pharmacology
Loading structure…
SMILES
C=C1CC[C@H](O)C/C1=C/C=C1\CCC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]12- Mol. weight
- 384.65 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Delivery
- Oral, Parenteral
- Availability
- Prescription Only
Oral
Yes
Parenteral
Yes
Topical
No
Sources
- ChEMBLCHEMBL1042 ↗
Also known as
- 7,8-didehydrocholesterol
- 7-dehydrocholesterol
- 7-dehydrocholesterol
- 7-dehydrocholesterol
- 7-dehydrocholesterol
- 7-dehydrocholesterol, (3alpha)-isomer
- 7-dehydrocholesterol, (3beta,10alpha)-isomer
- 7-dehydrocholesterol, (3beta,9beta,10alpha)-isomer
- 7-dehydrocholesterol, (3beta,9beta)-isomer
- 7-dhc
- cholesta-5,7-dien-3 beta-ol
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07012161 | Early Phase 1 (Phase 1) | Feb 20, 2025 | Bangladesh Medical University |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Bangladesh Medical University | Academic/Hospital | 1 | 1 | 1 | 2025 |
1 organizations
Page 1 / 1